Skip to main content
Year archive

Qurient Co., Ltd. — 2020 filings

All 42 regulatory filings released by Qurient Co., Ltd. (115180) in 2020, sourced directly from the official regulator.

42 Filings
2020 Period
2020 filings (42)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-16 Korean
투자판단관련주요경영사항(COVID-19 치료제 후보물질 텔라세벡(Telacebec) 임상 2상 시험 계획(IND) 승인)
Regulatory Filings
2020-11-24 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2020-11-06 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-11-02 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2020-10-29 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2020-10-29 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2020-10-26 Korean
투자판단관련주요경영사항(COVID-19 치료제 후보물질 텔라세벡(Telacebec) 임상 2상 시험 계획(IND) 신청)
Regulatory Filings
2020-10-13 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2020-09-22 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-08-28 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2020-08-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2020-07-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-07-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2020-06-30 Korean
[기재정정]유상증자결정(종속회사의주요경영사항)
Capital/Financing Update
2020-06-30 Korean
[기재정정]타법인주식및출자증권취득결정(독일 법인 QLi5 Therapeutics GmbH 출자 결정)
M&A Activity
2020-06-30 Korean
타법인주식및출자증권취득결정(독일 법인 QLi5 Therapeutics GmbH 출자 결정)
Share Issue/Capital Change
2020-06-11 Korean
유상증자결정(종속회사의주요경영사항)
Capital/Financing Update
2020-06-11 Korean
투자판단관련주요경영사항(아토피성 피부염 치료제 Q301의 임상 2b상 종료)
Regulatory Filings
2020-05-28 Korean
투자판단관련주요경영사항(면역항암치료제 Q702 미국 임상 1상 시험 계획(IND) 승인)
Regulatory Filings
2020-05-25 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2020-04-28 Korean
투자판단관련주요경영사항(면역항암치료제 Q702 미국 임상 1상 시험 계획(IND) 신청)
Regulatory Filings
2020-04-27 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-04-27 Korean
사업보고서 (2019.12)
Annual Report FY 2019
2020-03-30 Korean
[기재정정]정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2020-03-27 Korean
투자판단관련주요경영사항(Telacebec(Q203) 임상2a상 결과 NEJM에 논문 게재)
Regulatory Filings
2020-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-26 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2020-03-11 Korean
주주총회소집결의
AGM Information
2020-03-10 Korean
주주총회집중일개최사유신고
AGM Information
2020-03-10 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2020-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2020-03-10 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2019
2020-02-11 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-02-11 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-02-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2020-01-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-01-02 Korean